Aldeyra Therapeutics (ALDX) Reports Q1 Loss of $0.34/sh

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.34), versus ($0.58) reported last year.

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Sun Communities names Ileana McAlary as general counsel and EVP
• C.H. Robinson acquires DeSpir Logistics for $75 million